Publication:
The Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease

Simple item page
dc.contributor.authorÖzlü, Tuğçe
dc.contributor.authorErzin, Yusuf
dc.contributor.authorKenger, Emre Batuhan
dc.contributor.authorGüveli, Hakan
dc.contributor.authorÇelik, Kevser
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionİstanbul Üniversitesi - Cerrahpaşa
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionBahçeşehir Üniversitesi
dc.date.accessioned2025-09-20T19:55:33Z
dc.date.issued2023
dc.date.submitted20.07.2023
dc.description.abstractBackground/Aims: Mediterranean diet, owing to its infla mmation-modulatory effects, is considered a beneficial dietary regimen for patients with inflammatory bowel disease. Despite promising results in the literature, studies on this subject are still limited. Therefore, the aim of this study was to evaluate adherence to the Mediterranean diet in patients with inflammatory bowel disease and examine its impact on disease activity and quality of life. Materials and Methods: A total of 83 patients were included in the study. Mediterranean Diet Adherence Scale was used to evaluate adherence to the Mediterranean diet. Crohn’s Disease Activity Index was used to evaluate disease activity in Crohn’s disease. Disease activity was determined by using the Mayo Clinic score for ulcerative colitis. Quality of Life Scale Short Form-36 was used to evaluate the quality of life of patients. Results: When the median Mediterranean Diet Adherence Scale score was 7 (1-12), only 18 patients (21.7%) showed strong adherence to the Mediterranean diet. Disease activity scores of patients with ulcerative colitis having low adherence to the Mediterranean diet were found to be higher (P < .05). In addition, some quality of life parameters were relatively higher in patients with ulcerative colitis who showed strong adherence to the Mediterranean diet (P < .05). For Crohn’s disease, no significant difference was found in disease activity and quality of life with respect to adherence to the Mediterranean diet (P > .05). Conclusion: Stronger adherence to the Mediterranean diet in patients with ulcerative colitis can help improve quality of life and modu- late disease activity. However, further prospective studies are needed to investigate the potential use of the Mediterranean diet in inflammatory bowel disease management.
dc.identifier.doi10.5152/tjg.2023.22193
dc.identifier.endpage719
dc.identifier.issn1300-4948
dc.identifier.issn2148-5607
dc.identifier.issue7
dc.identifier.startpage714
dc.identifier.urihttps://hdl.handle.net/20.500.14719/4553
dc.identifier.volume34
dc.language.isoen
dc.relation.journalTurkish Journal of Gastroenterology
dc.subjectBeslenme ve Diyetetik
dc.subjectGenel ve Dahili Tıp
dc.subjectPatoloji
dc.titleThe Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease
dc.typeResearch Article
dcterms.references1. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and preva- lence of inflammatory bowel disease in the 21st century: a system- atic review of population-based studies. Lancet. 2017,390(10114):2769-2778. [CrossRef],2. Cosnes J, Gower–Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterol- ogy. 2011,140(6):1785-1794. [CrossRef],3. Can G, Poşul E, Yılmaz B, et al. Epidemiologic features of inflam- matory bowel disease in western BlackSea region of Turkey for the last 10 years: retrospective cohort study. Korean J Intern Med. 2019,34(3):519-529. [CrossRef],4. Tozun N, Atug O, Imeryuz N, et al. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009,43(1):51-57. [CrossRef],5. Limketkai BN, Wolf A, Parian AM. Nutritional interventions in the patient with inflammatory bowel disease. Gastroenterol Clin North Am. 2018,47(1):155-177. [CrossRef],6. Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018,11(1):1-10. [CrossRef],7. Rapozo DC, Bernardazzi C, de Souza HSP. Diet and microbiota in inflammatory bowel disease: the gut in disharmony. World J Gastro- enterol. 2017,23(12):2124-2140. [CrossRef],8. Serrano-Moreno C, Brox-Torrecilla N, Arhip L, et al. Diets for inflammatory bowel disease: what do we know so far? Eur J Clin Nutr. 2022,76(9):1222-1233. [CrossRef],9. Weber AT, Shah ND, Sauk J, Limketkai BN. Popular diet trends for inflammatory bowel diseases: claims and evidence. Curr Treat Options Gastroenterol. 2019,17(4):564-576. [CrossRef],10. Rosato V, Temple NJ, La Vecchia C, Castellan G, Tavani A, Guer- cio V. Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies. Eur J Nutr. 2019,58(1):173-191. [CrossRef],11. Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. Adher- ence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients. 2017,9(10):1063. [CrossRef],12. Singh B, Parsaik AK, Mielke MM, et al. Association of Mediterra- nean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014,39(2): 271-282. [CrossRef],13. Khalili H, Håkansson N, Chan SS, et al. Adherence to a Mediter- ranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut. 2020,69(9):1637-1644. [CrossRef],14. Papada E, Amerikanou C, Forbes A, Kaliora AC. Adherence to Mediterranean diet in Crohn’s disease. Eur J Nutr. 2020,59(3):1115- 1121. [CrossRef],15. Galilea-Zabalza I, Buil-Cosiales P, Salas-Salvadó J, et al. Mediter- ranean diet and quality of life: baseline cross-sectional analysis of the PREDIMED-PLUS trial. PLOS ONE. 2018,13(6):e0198974. [CrossRef],16. Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka- Walus A. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses—part II. Inflamm Bowel Dis. 2018,24(5): 966-976. [CrossRef],17. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology. 1976,70(3):439-444. [CrossRef],18. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-amino- salicylic acid therapy for mildly to moderately active ulcerative coli- tis. A randomized study. N Engl J Med. 1987,317(26):1625-1629. [CrossRef],19. Schröder H, Fitó M, Estruch R, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011,141(6):1140-1145. [CrossRef],20. Pehlivanoglu EFÖ, Balcioglu H, Unluoglu I. Akdeniz Diyeti Bağlılık Ölçeği’nin Türkçe’ye Uyarlanması Geçerlilik Ve güvenilirliği. Osman- gazi Tıp Derg. 2020,42(2):160-164.,21. Ware JE JR, Sherbourne CD. The Maryland Ornithological Society 36-item short-form health survey (SF36). I. Conceptual framework and item selection. Med Care. 1992,30(6):473-483.,22. Kocyigit H, Aydemir O, Fisek G. Kısa Form-36 nın Türkçe versiyo- nunun güvenilirliği ve geçerliliği. İlaç Tedavi Derg. 1999,12:102-106.,23. Fiorindi C, Dinu M, Gavazzi E, et al. Adherence to Mediterranean diet in patients with inflammatory bowel disease. Clin Nutr ESPEN. 2021,46:416-423. [CrossRef],24. Weisshof R, Chermesh I. Micronutrient deficiencies in inflamma- tory bowel disease. Curr Opin Clin Nutr Metab Care. 2015,18(6):576- 581. [CrossRef],25. Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterol- ogy. 2014,146(6):1489-1499. [CrossRef],26. Tomasello G, Mazzola M, Leone A, et al. Nutrition, oxidative stress and intestinal dysbiosis: influence of diet on gut microbiota in inflammatory bowel diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016,160(4):461-466. [CrossRef],27. Godny L, Reshef L, Pfeffer-Gik T, et al. Adherence to the Mediter- ranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. Eur J Nutr. 2020,59(7):3183-3190. [CrossRef],28. Casellas F, López-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res. 2002,11(8):775-781. [CrossRef],29. Lo C, Khalili H, Song M, et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021,19(1):87-95.,30. Aleksandrova K, Romero-Mosquera B, Hernandez V. Diet, gut microbiome and epigenetics: emerging links with inflammatory bowel diseases and prospects for management and prevention. Nutrients. 2017,9(9):962. [CrossRef]
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The Effect of Adherence to Mediterranean Diet on Disease Activity in Patients with Inflammatory Bowel Disease.pdf
Size:
851.18 KB
Format:
Adobe Portable Document Format
Download

Collections

TR-Dizin İndeksli Yayınlar Koleksiyonu